RELATED CONTENT
NEWS
- Indian firms lead para IV charge, lock in key first-to-file opportunities
- Asia Beat: Takeda + Nycomed = panic buy or strategic masterstroke?
- Alarming 17.1% jump in US specialty drug spend may still underestimate hidden costs
- Teva sees growth in 2012 and authorises $3 billion buyback
COMMENT
Other Informa Comment
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

